Immune thrombocytopenic purpura may not cause any symptoms or may have symptoms that are easily confused with other diseases. Therefore, without knowledge about autoimmune thrombocytopenia, the disease will be detected late and the risk of complications is very high.

Treatment regimen for immune thrombocytopenic purpura will depend on the patient's platelet count, symptoms, and age. If the patient has no signs of bleeding and the platelet count is not too low, treatment is not necessary. However, if the disease progresses severely, medication or surgical intervention may be required.

Immune thrombocytopenic purpura, also known as immune thrombocytopenic purpura, is an immune disease, which is a condition of thrombocytopenia caused by antibodies that can self-generate and adhere to platelet membrane antigens, causing symptoms of thrombocytopenia in peripheral blood. The disease needs to be detected and treated properly to avoid causing some dangerous complications.

Idiopathic thrombocytopenic purpura is an autoimmune disease in humans, caused by a decrease in platelets in the body and affects the body's ability to stop bleeding and clot blood when there is a wound or slight impact. The disease is common in all ages, but the most common is thrombocytopenic purpura in newborns and often leaves very serious complications.

Immune thrombocytopenia (ITP) is a blood clotting disorder. It is caused by a low platelet count because the immune system attacks healthy platelets. If you are not bleeding and your platelet count is not too low, no treatment is needed. However, if your condition becomes more severe, you may need medication or surgery.

Idiopathic thrombocytopenic purpura is a disease of the platelets that leads to blood clotting disorders and affects the clotting function. Some questions are raised: can idiopathic thrombocytopenia be cured?